Filing Details
- Accession Number:
- 0001209191-21-055488
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-09-10 17:12:46
- Reporting Period:
- 2021-04-16
- Accepted Time:
- 2021-09-10 17:12:46
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1087294 | Cumberland Pharmaceuticals Inc | CPIX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1684087 | Caroline Young | 2525 West End Avenue Suite 950 Nashville TN 37203 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-04-16 | 15 | $3.03 | 11,948 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-04-19 | 15 | $3.04 | 11,963 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-04-20 | 15 | $3.02 | 11,978 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-04-21 | 15 | $2.97 | 11,993 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-04-22 | 15 | $2.96 | 12,008 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-04-23 | 15 | $2.99 | 12,023 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-04-26 | 15 | $2.97 | 12,038 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-04-27 | 15 | $2.94 | 12,053 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-04-28 | 15 | $2.94 | 12,068 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-04-29 | 15 | $2.89 | 12,083 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-04-30 | 15 | $2.78 | 12,098 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-05-03 | 15 | $2.66 | 12,113 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-05-04 | 15 | $2.66 | 12,128 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-05-05 | 15 | $2.73 | 12,143 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-05-06 | 15 | $2.74 | 12,158 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-05-07 | 15 | $2.73 | 12,173 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-05-10 | 15 | $2.71 | 12,188 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-05-11 | 15 | $2.68 | 12,203 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-05-12 | 15 | $2.86 | 12,218 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-05-13 | 15 | $2.88 | 12,233 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-05-14 | 15 | $2.81 | 12,248 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-05-17 | 15 | $2.84 | 12,263 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-05-18 | 15 | $2.89 | 12,278 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-05-19 | 15 | $2.83 | 12,293 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-05-20 | 15 | $2.94 | 12,308 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-05-21 | 15 | $3.06 | 12,323 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-05-24 | 15 | $3.05 | 12,338 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-05-25 | 15 | $2.91 | 12,353 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-05-26 | 15 | $2.85 | 12,368 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-05-27 | 15 | $2.94 | 12,383 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.